UK Companies House feature
IPULSE LIMITED
Cash
£8K
+73.1% vs 2023
Net assets
£4M
+1,076.3% vs 2023
Employees
276
+4.9% vs 2023
Profit before tax
—
Period ending 2024-12-31
Profile
- Company number
- 08306196
- Status
- Active
- Incorporation
- 2012-11-23
- Last accounts made up
- 2024-12-31
- Account category
- GROUP
- Primary SIC
- 32500
- Hubs
- UK Healthcare
Cash
7-year trend · vs UK Healthcare median
Accounts
7-year trend · latest 2024-12-31
| Metric | Trend | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | — | — | — | |
| Net profit | — | — | — | — | — | — | £4,092,239 | |
| Cash | — | — | — | — | — | £4,833 | £8,367 | |
| Total assets less current liabilities | — | — | — | — | — | £380,223 | £4,472,462 | |
| Net assets | — | — | — | — | — | — | — | |
| Equity | £3,986,713 | £3,097,890 | £906,557 | £1,255,069 | £659,258 | £380,223 | £4,472,462 | |
| Average employees | — | — | — | — | — | 263 | 276 | |
| Wages | — | — | — | — | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated (group)
- Auditor
- Bevan Buckland LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have considered the financial position of the Company and its forecast performance and are satisfied that it is appropriate to adopt the going concern basis in preparing the financial statements.”
Subsidiaries
- CyDen Limited · 100% held · United Kingdom · Design, manufacturing & sales
- CyDen Japan Co., Ltd · 100% held · Japan · Sales
- iPulse Direct Limited · 100% held · United Kingdom · Dormant
- Cyden Medical Technology (Zhejiang) Co., Ltd · 100% held · China · Manufacturing and sales
- Cyden Medical Technology Guangxi Co Ltd · 100% held · China · Quality and Regulatory
- Cyden US Corp · 100% held · United States of America · Sales
- MC500 Limited · 100% held · United Kingdom · Dormant
Significant events
- “There were no events after the reporting period to the date the accounts were approved that are material for disclosure in the financial statements.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
7 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DYKES, Jonathan | Secretary | 2023-01-30 | — | — |
| AVIS, Alice Mary Cleoniki | Director | 2013-09-01 | May 1962 | British |
| BECKETT, Thomas Edward | Director | 2019-04-02 | Mar 1962 | British |
| CLEMENT, Robert Marc, Prof | Director | 2013-09-01 | Nov 1953 | British |
| REEVE, Jamie Martin | Director | 2017-11-08 | Jul 1964 | British |
| RUDD, Nigel Russell, Sir | Director | 2013-09-01 | Dec 1946 | British |
| VAN ROZEN, Robin | Director | 2023-02-01 | Jun 1974 | Dutch |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BECKETT, Thomas Edward | Director | 2013-09-01 | 2015-08-04 |
| BRAMPTON, Anthony David | Director | 2015-11-11 | 2019-04-02 |
| DAVIES, Giles Alexander | Director | 2012-11-23 | 2023-01-26 |
| OUTRAM, Christopher David | Director | 2013-09-01 | 2017-09-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Richard Koch | Individual | Shares 50–75%, Voting 50–75% | 2016-04-06 | Active |
Filing timeline
Last 20 of 81 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-17 | SH01 | capital | capital allotment shares |
| 2025-12-04 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-12-04 | SH01 | capital | capital allotment shares |
| 2025-08-22 | AA | accounts | accounts with accounts type group |
| 2025-02-17 | RP04CS01 | confirmation-statement | second filing of confirmation statement with made up date |
| 2025-02-13 | SH01 | capital | capital allotment shares |
| 2025-01-07 | CS01 | confirmation-statement | confirmation statement |
| 2024-09-30 | AA | accounts | accounts with accounts type group |
| 2024-08-30 | RESOLUTIONS | resolution | resolution |
| 2024-08-30 | MA | incorporation | memorandum articles |
| 2024-08-27 | AP03 | officers | appoint person secretary company with name date |
| 2023-12-07 | CS01 | confirmation-statement | confirmation statement with updates |
| 2023-09-28 | AA | accounts | accounts with accounts type group |
| 2023-07-05 | RESOLUTIONS | resolution | resolution |
| 2023-06-26 | MA | incorporation | memorandum articles |
| 2023-02-01 | AP01 | officers | appoint person director company with name date |
| 2023-01-26 | TM01 | officers | termination director company with name termination date |
| 2022-11-28 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-09-29 | AA | accounts | accounts with accounts type group |
| 2021-12-02 | CS01 | confirmation-statement | confirmation statement with updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Composite activity score · components 0–100 · reference 2026-05-10
46.6
COOL
/ 100
- Filings velocity 33
- Capital events 60
- Officer churn 0
- Headcount trajectory 55
- Accounts trajectory 100
- 4 filing(s) in last 12 months
- 3 capital event(s) in last 24 months
- Employees +5% YoY
- Total Assets Less Current Liabilities +1076% YoY